Europe Insulin Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Insulin Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Insulin Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Insulin Market Regional Analysis

6.2 Europe Insulin Market Revenue 2020-2028 (US$ Million)

6.3 Europe Insulin Market Forecast Analysis

7. Europe Insulin Market Analysis – by Type

7.1 Long Acting Insulin

7.1.1 Overview
7.1.2 Long Acting Insulin: Europe Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Rapid Acting Insulins

7.2.1 Overview
7.2.2 Rapid Acting Insulins: Europe Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Short acting Insulins and Traditional Human Insulins

7.3.1 Overview
7.3.2 Short acting Insulins and Traditional Human Insulins: Europe Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Concentrated Insulins and Combination Insulins

7.4.1 Overview
7.4.2 Concentrated Insulins and Combination Insulins: Europe Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.5 Biosimilar Insulins

7.5.1 Overview
7.5.2 Biosimilar Insulins: Europe Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.6 Glucagon-like peptide-1

7.6.1 Overview
7.6.2 Glucagon-like peptide-1: Europe Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.7 Pens and Needles

7.7.1 Overview
7.7.2 Pens and Needles: Europe Insulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Insulin Market – Europe Analysis

8.1 Overview

8.2 Europe

8.2.1 Europe Insulin Market Breakdown, by Key Country, 2023 and 2028 (%)
8.2.1.1 Europe Insulin Market – Revenue and Forecast Analysis – by Country
8.2.1.1 UK: Europe Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.1.1 UK: Europe Insulin Market Breakdown, by Type

8.2.1.2 Germany: Europe Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.2.1 Germany: Europe Insulin Market Breakdown, by Type

8.2.1.3 France: Europe Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.3.1 France: Europe Insulin Market Breakdown, by Type

8.2.1.4 Russia: Europe Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.4.1 Russia: Europe Insulin Market Breakdown, by Type

8.2.1.5 Italy: Europe Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.5.1 Italy: Europe Insulin Market Breakdown, by Type

8.2.1.6 Rest of Europe: Europe Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.1.6.1 Rest of Europe: Europe Insulin Market Breakdown, by Type

9. Competitive Landscape

9.1 Heat Map Analysis

9.2 Company Positioning and Concentration

10. Industry Landscape

10.1 Overview

10.2 Market Initiative

10.3 Partnerships and Collaborations

10.4 Other Developments

11. Company Profiles

11.1 Adocia

11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments

11.2 Biocon

11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments

11.3 Eli Lilly and Company

11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments

11.4 GlaxoSmithKline plc.

11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments

11.5 Merck & Co., Inc.

11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

11.6 Novo Nordisk A/S

11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments

11.7 Pfizer Inc.

11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments

11.8 Sanofi

11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments

11.9 Tonghua Dongbao Pharmaceutical Co., Ltd.

11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments

11.10 Wockhardt

11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix

12.1 About Business Market Insights

12.2 List of Abbreviations

Europe Insulin Market

Analysis – by Type (Long Acting Insulin, Rapid Acting Insulins, Short acting Insulins and Traditional Human Insulins, Concentrated Insulins and Combination Insulins, Biosimilar Insulins, Glucagon-like peptide-1 (GLP-1), Pens and Needles, and Others)